Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -29,856
▲ 69% vs 2024
Profit
Caution€ -30,886
▲ 68% vs 2024
Debts
Low€ 2,537
▼ 43% vs 2024
CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE from Liège, company number BE0538751856, closed financial year 2025 with a result of € -30,886 after tax. For that financial year CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE recorded a gross margin of € -29,856 and equity of € 199,574. Compared with financial year 2024, the result moved from € -97,236 to € -30,886. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 4, 2026.
What happened at CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE?
What happened at CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 30,886. Source: NBB ↗
- Jean-Marc Kaufman became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 11,484 loss in 2022 to € 30,886 loss in 2025.
A new publication or filing at CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE? We notify you, reason included.
Follow CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE is Jean-Marc Kaufman. Jean-Marc Kaufman is also behind European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
Directors
According to the 2025 annual accounts
Jean-Marc Kaufman
Director
Also active at: European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
since 2023
Establishments
Establishment units
Physical locations of this company
Quai Godefroid-Kurth 13
4020 Liège
Quai Godefroid-Kurth 4
4020 Liège
Active since 19 September 2013
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
Ici ou là...
SaLes
€ 29,471 gross margin · 2025
BCM - ENERGIE & CONFORT
€ 4,134 gross margin · 2024
Association des Copropriétaires Résidence Bizet à Liège Quai Godefroid Kurth 13
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases same network
€ 280,686 gross margin · 2025
Details
- Company number
- 0538.751.856
- VAT number
- BE 0538.751.856
- Registered office
- Quai Godefroid-Kurth 13, 4020 Liège
- Names & denominations
- CENTRE ACADEMIQUE DE RECHERCHE ET D'EXPERIMENTATION EN SANTE · CARES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 September 2013
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- 04/344.37.69
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied